Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

APYXAPYX
Showing 8 of 28 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in APYX MEDICAL CORPORATION

No. BNP Paribas Financial Markets exited its APYX (Apyx Medical) position in Q2 2026. Its Q1 2026 13F listed 15 shares worth $55. BNP Paribas Financial Markets first reported APYX in Q2 2019 and held it in 26 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$19

Total Shares Change

-15

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$4.49
0
2026-Q1
Unchanged
15
0.0%
$550.0%$3.69
0
2025-Q4
Unchanged
15
0.0%
$520.0%$3.50
0
2025-Q3
Unchanged
15
0.0%
$320.0%$2.14
0
2025-Q2
Unchanged
15
0.0%
$340.0%$2.25
0
2025-Q1
Unchanged
15
0.0%
$210.0%$1.37
0
2024-Q4
Unchanged
15
0.0%
$240.0%$1.58
0
2024-Q3
Unchanged
15
0.0%
$190.0%$1.24
0

Other major holders of APYX: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used